The Evolving Role of Neutrophils in Liver Transplant Ischemia-Reperfusion Injury
- PMID: 31602356
- PMCID: PMC6786799
- DOI: 10.1007/s40472-019-0230-4
The Evolving Role of Neutrophils in Liver Transplant Ischemia-Reperfusion Injury
Abstract
Purpose of review: Hepatic ischemia-reperfusion injury (IRI), an inevitable event during liver transplantation, represents a major risk factor for the primary graft dysfunction as well as the development of acute and chronic rejection. Neutrophils, along macrophages are pivotal in the innate immune-driven liver IRI, whereas the effective neutrophil targeting therapies remain to be established. In this review, we summarize progress in our appreciation of the neutrophil biology and discuss neutrophil-based therapeutic perspectives.
Recent findings: New technological advances enable to accurately track neutrophil movements and help to understand molecular mechanisms in neutrophil function, such as selective recruitment to IR-stressed tissue, formation of neutrophil extracellular traps, or reverse migration into circulation. In addition to pro-inflammatory and tissue-destructive functions, immune regulatory and tissue-repairing phenotype associated with distinct neutrophil subsets, have been identified.
Summary: Newly recognized and therapeutically attractive neutrophil characteristics warrant comprehensive preclinical and clinical attention to target IRI in transplant recipients.
Keywords: homeostasis recovery; liver ischemia-reperfusion injury; neutrophil; neutrophil extracellular traps; reverse migration.
Conflict of interest statement
Conflict of Interest Kojiro Nakamura, Shoichi Kageyama, and Jerzy W. Kupiec-Weglinski declare no conflict of interest.
Figures
References
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials